Valuation: QuidelOrtho Corporation

Market Cap 981M 847M 794M 723M 1.36B 93.76B 1.38B 9.31B 3.65B 46.97B 3.68B 3.6B 156B P/E 2026 *
-3.47x
P/E 2027 * -5.14x
Enterprise Value 3.54B 3.06B 2.87B 2.61B 4.91B 338B 4.98B 33.6B 13.17B 170B 13.29B 13B 564B EV / Sales 2026 *
1.39x
EV / Sales 2027 * 1.34x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day+1.36%
1 week+5.67%
Current month-13.36%
1 month-16.40%
3 months+34.04%
6 months-37.18%
Current year-49.12%
1 week 13.28
Extreme 13.28
15.52
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Tech/Sci/R&D Officer 44 2024-10-06
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+5.67%-43.73%-80.17% 981M
-1.52%-1.97%+20.35%-36.44% 17.1B
-0.40%+0.04%-10.65%+97.44% 1.76B
-0.66%-2.88%-25.54%+24.62% 985M
+0.03%+0.16%+67.63%-7.18% 779M
-0.51%+1.93%-36.59%-50.32% 696M
-1.54%+15.98%-36.32%-39.87% 646M
-0.97%+6.11%-40.79%-37.38% 443M
+3.80%+18.41%+66.19%+44.52% 414M
-0.92%-0.66%-4.66%-18.51% 383M
Average -0.08%+9.36%-4.41%-10.33% 2.42B
Weighted average by Cap. -1.00%+4.34%+11.27%-23.88%

Financials

2026 *2027 *
Net sales 2.55B 2.2B 2.06B 1.88B 3.53B 243B 3.58B 24.17B 9.47B 122B 9.56B 9.35B 406B 2.59B 2.24B 2.1B 1.91B 3.59B 248B 3.64B 24.61B 9.64B 124B 9.73B 9.52B 413B
Net income -269M -232M -218M -198M -373M -25.72B -378M -2.55B -1B -12.89B -1.01B -988M -42.87B -164M -142M -133M -121M -227M -15.67B -231M -1.56B -610M -7.85B -615M -602M -26.12B
Net Debt 2.56B 2.21B 2.07B 1.89B 3.55B 245B 3.6B 24.29B 9.52B 123B 9.6B 9.4B 408B 2.49B 2.15B 2.02B 1.84B 3.46B 238B 3.5B 23.65B 9.27B 119B 9.35B 9.15B 397B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-17 US$14.52 +1.50% 355,205
26-08-14 US$14.30 -5.24% 917,947
26-08-13 US$15.09 +1.75% 1,446,395
26-08-12 US$14.83 +6.00% 1,953,334
26-08-11 US$13.99 +1.75% 1,495,558
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
14.30USD
Average target price
14.67USD
Spread / Average Target
+2.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock